SIGMA 7 PRODUCTS INC
10QSB, 1997-10-30
BLANK CHECKS
Previous: CALLAWAY GOLF CO /CA, S-8, 1997-10-30
Next: IDS GLOBAL SERIES INC, 40-17F2, 1997-10-30



                                                           
  

                  SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C.  20549


                              FORM 10-QSB



          Quarterly Report Pursuant to Section 13 or 15(d) of
                  the Securities Exchange Act of 1934


    For Quarter Ended June 30, 1997      Commission File No. 0-17700


                        SIGMA-7 PRODUCTS, INC.
        (Exact name of Registrant as specified in its charter)


                 COLORADO                           84-1095500
      (State or other jurisdiction of      (I.R.S. Empl. Ident. No.)
      incorporation or organization)


           2501 East 3rd Street
              Casper, Wyoming                          82609
 (Address of Principal Executive Offices)           (Zip Code)


                            (307) 235-0012
         (Registrant's Telephone Number, including Area Code)


Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or such shorter period that the
Registrant was required to file such reports), and (2) has been subject to
such filing to such filing requirements for at least the past 90 days.

                     Yes               No   X  

The number of shares outstanding of each of the Registrant's classes of
common equity, as of June 30, 1997 are as follows:


           Class of Securities                  Shares Outstanding
           -------------------                  ------------------
        Common Stock, no par value                 758,287,497




                                 INDEX
                                                                  Page of
                                                                   Report 

      PART I. FINANCIAL INFORMATION


Item 1.  Financial Statements.

      Balance Sheets:

      As of June 31, 1997 (Unaudited) and September 30, 1996 ........     3

      Statement of Operations (Unaudited):

      For the three months and nine months ended June 30, 1997 
      and Cumulative from inception (October 3, 1988) through
      
      June  30, 1997.................................................     4

      Statements of Cash Flows (Unaudited): 

      For the three months and nine months ended June 30, 1997 
      and Cumulative from inception (October 3, 1988) through
      June 30, 1997..................................................     5

      Notes to Financial Statements (Unaudited) .....................     6


Item 2.  Management's Discussion and Analysis or Plan of Operation ..     7


      PART II.     OTHER INFORMATION


Item 6.  Exhibits and Reports on Form 8-K ...........................     8


      Signatures ....................................................     8









                        SIGMA-7 PRODUCTS, INC.
                     (A DEVELOPMENT STAGE COMPANY)
                            BALANCE SHEETS
                                   

                                ASSETS


                                             March 31,         September 30,
                                                1997                1996  
                                             ----------        -------------
                                             (Unaudited)           (Note) 
  
Current assets:
  Cash                                       $      18         $     1,431
                                             ===========       =============  



                 LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Accounts payable                           $   3,337         $       536
                                             -----------       -------------

      Total current liabilitie                   3,337                 536
                                             -----------       ------------- 

Stockholders' equity:
  Preferred stock, no par value,
      10,000,000 shares authorized;
      none issued and outstanding
  Common stock, no par value;
      1,000,000,000 shares authorized;
      758,287,497 shares issued and 
      outstanding at June 30, 1997
      and September 30, 1996.                  430,715              430,715
  Contributed capital                           20,250               12,750
  Deficit accumulated during the 
      development stage                       (454,284)            (442,570)
                                             -----------       -------------

      Total stockholders' (deficit)             (3,319)                 895
                                             -----------       -------------

                                             $      18         $      1,431
                                             ===========       =============



Note:  Taken from the audited balance sheet at that date.



                See accountants' disclaimer of opinion.





                        SIGMA-7 PRODUCTS, INC.
                     (A DEVELOPMENT STAGE COMPANY)
                       STATEMENTS OF OPERATIONS
                                   


   
                                                             October 3, 1988
                             Three months      Nine months       (Inception)  
                                 ended            ended               to  
                            June 30, 1997     June 30, 1997   June 30, 1997
                            --------------   --------------   --------------
                             (Unaudited)       (Unaudited)      (Unaudited)

Revenue                     $        -       $         -      $     20,966
                            -------------    --------------   --------------

Operating expenses:
  General and                  
     administration               1,591            11,714          496,361
  Interest expense                   -                 -            35,917
  Amortization                       -                 -               250
                            -------------    --------------   -------------- 
                                  1,591            11,714          532,528
                            -------------    --------------   --------------

Other income                         -                 -            51,160
                            -------------    --------------   --------------

Income (loss) before 
  extraordinary item:            (1,591)          (11,714)        (460,402)

Extraordinary items:
  Gain on conversion of 
     debt to equity                  -                 -             6,118
                            --------------   --------------   -------------- 
  
Net income (loss)           $    (1,591)     $    (11,714)    $   (454,284)
                            ==============   ==============   ==============

Net loss per share                   *                 *                *
                            ==============   ==============   ==============

Weighted average
   number of common
   shares outstanding         758,287,497     758,287,497      325,955,084
                            ==============   ==============   ==============


* less than $.01 per share



                 See accountants' disclaimer of opinion.



                        SIGMA-7 PRODUCTS, INC.
                     (A DEVELOPMENT STAGE COMPANY)
                       STATEMENTS OF CASH FLOWS
                                   

                                                               October 3, 1988
                               Three Months     Nine Months       (Inception)
                                   ended           ended              to
                              June 30, 1997    June 30, 1997    June 30, 1997
                              --------------   --------------   --------------
                               (Unaudited)      (Unaudited)       (Unaudited)
                                     
Cash flows from operating 
  activities:
Net (loss) income             $     (1,591)    $   (11,714)     $   (454,284)

Adjustments to reconcile net
  income(loss) to net cash 
  provided by operating 
  activities:
Amortization                            -               -                250

Cash provided (used) due to 
  changes in assets and 
  liabilities:
Issuance of common stock
  for services                          -               -             42,700
Other income                            -               -            (51,160)
Accounts payable                    (7,072)          2,801            39,805
Accrued interest and expense            -               -             12,281
                               ------------   -------------   ---------------

Net cash used by operating 
  activities                        (8,663)         (8,913)         (410,408)
                               ------------   -------------   ---------------

Cash flows from financing activities:
Net proceeds from issuance of common
   stock:
      For cash                          -              -             195,405
      For conversion of debt            -              -             211,132
Increase in notes payable               -              -               1,213
Deferred offering costs                 -              -             (17,324)
Contributed capital                  7,500          7,500             20,250
Increase in organization costs          -              -                (250)
                              -------------   -------------   --------------- 

Net cash provided by financing
  activities                         7,500          7,500            410,426
                              -------------   -------------   ---------------

Net increase (decrease) in cash
  and cash equivalent               (1,163)        (1,431)                18


Cash and cash equivalents,
  beginning of period                1,181          1,431                 -
                              -------------   --------------   --------------

Cash and cash equivalents,
  end of period               $         18    $        18      $          18
                              =============   ==============   ==============
   



                 See accountants' disclaimer of opinion.





                        SIGMA-7 PRODUCTS, INC.
                     (A DEVELOPMENT STAGE COMPANY)
                     NOTES TO FINANCIAL STATEMENTS



NOTE 1  CONDENSED FINANCIAL STATEMENTS

        The financial statements included herein have been prepared by
        SIGMA-7 Products, Inc. (the "Company") without audit, pursuant to the
        rules and regulations of the Securities and Exchange Commission. 
        Certain information and footnote disclosures normally included in
        financial statements prepared in accordance with generally accepted
        accounting principles have been condensed or omitted as allowed by
        such rules and regulations, and the company believes that the dis-
        closures are adequate to make the information presented not mislead-
        ing.  It is suggested that these financial statements be read in
        conjunction with the September 30, 1996 audited financial statements
        and the accompanying notes thereto.  While management believes the
        procedures followed in preparing these financial statements are
        reasonable, the accuracy of the amounts are in some respects depen-
        dent upon the facts that will exist, and procedures that will be
        accomplished by the Company later in the year.  

        The management of the Company believes that the accompanying un-
        audited condensed financial statements contain all adjustments
        (including normal recurring adjustment) necessary to present fairly
        the operations and cash flows for the periods presented.



Item 2. Management's Discussion and Analysis or Plan of Operation.

        Background.
        -----------
        
        The Company was incorporated in the State of Colorado under the name
        of Seek-2 Ventures, Inc. on October 3, 1988 as a blind pool corpora-
        tion for the purpose of obtaining capital to take advantage of domes-
        tic and foreign business opportunities.  On April 13, 1989, the
        Company completed its initial public offering of 11,460,000 shares of
        stock raising the approximate net sum of $93,467.

        On April 19, 1989, the Company amended its Articles of Incorporation
        changing the Company's name to Sigma-7 Products, Inc.  Subsequently,
        on January 25, 1992 the Company changed its name to Global Develop-
        ment Group, Inc. and back again to Sigma-7 Products, Inc. on May 25,
        1995.

        During the period between April 19, 1989 and approximately March 1,
        1991, the Company engaged in the manufacture of electronic
        self-protection devices commonly referred to as "stun-guns".  During
        1991 the Company determined that pursuing the stun gun manufacturing
        business would require substantially more funds than it could reason-
        ably expect to raise in the near future, Further, various economic,
        governmental and regulatory agencies brought focus on the industry in
        such a manner that it did not appear to be in the Company's best
        interest to pursue this endeavor.  During late February and early
        March 1991, the Company ceased to operate that business due to a lack
        of working capital and extended debt.

        Subsequent to January 1, 1991, the Company engaged in a financial
        restructuring to eliminate as much debt as possible and to make the
        Company attractive for acquisition and/or merger with qualified
        individuals and companies with existing operations.

        The Company's sole business at this point is to seek to acquire
        assets of or an interest in a small to medium-size company or venture
        actively engaged in a business generating revenues or having
        immediate prospects of generating revenues. The Company plans to
        acquire such assets or shares by exchanging therefor the Company's
        securities. In order to avoid becoming subject to regulation under
        the Investment Company Act of 1940, as amended, the Company does not
        intend to enter into any transaction involving the purchase of
        another corporation's stock unless the Company can acquire at least a
        majority interest in that corporation. The Company has not identified
        any industry, segment within an industry or type of business, nor
        geographic area, in which it will concentrate its efforts, and any
        assets or interest acquired may be in any industry or location,
        anywhere in the world. The Company will give preference to profitable
        companies or ventures with a significant asset base sufficient to
        support a listing on a national securities exchange or quotation on
        the NASDAQ system. Members of management (all of whom are devoting
        part time to the Company's affairs) plan to search for an operating
        business or venture which the Company can acquire, thereby becoming
        an operating company. There is no assurance that the Company will be
        successful in this endeavor. The Company has no operations or source
        of revenues. Unless the Company succeeds in acquiring a company or
        properties which provide cash flow, the Company's ability to survive
        is in doubt.


        Financial Condition.
        --------------------

        During the quarter ended June 30, 1997 (third quarter of the fiscal
        year), the Company had no revenues and did not have operations.
        Expenses for this period were nominal resulting in a loss of $1,591.
        The Company has, since inception, accumulated a deficit (net loss)
        through the end of this quarter of $454,284.


        Liquidity and Capital Resources.
        --------------------------------

        The Company had $18 cash on hand at the end of the quarter. The
        Company had no other cash or other assets, nor any current plans to
        raise capital. Whether the Company ultimately becomes a going concern
        depends upon its success in finding and acquiring a suitable private
        business and the success of that acquired business. At this time, the
        Company has no commitment for any capital expenditure and foresees
        none. Offices are provided without charge to the Company. However,
        the Company will incur routine fees and expenses incident to filing
        of periodic reports with the Securities and Exchange Commission, and
        it will incur fees and expenses in the event it makes or attempts to
        make an acquisition. As a practical matter, the Company expects no
        significant operating costs other than professional fees payable to
        attorneys and accountants.

        In regard to a proposed acquisition, the Company anticipates requir-
        ing the target company to deposit with the Company a retainer which
        the Company can use to defray such professional fees and costs. In
        this way, the Company could avoid the need to raise funds for such
        expenses or becoming indebted to such professionals. Moreover,
        investigation of business ventures for potential acquisition will
        involve some costs, at the least postage and long-distance telephone
        charges. Management hopes, once a candidate business venture is
        deemed to be appealing, to likewise secure a deposit from the
        business venture to defray expenses of further investigation, such as
        air travel and lodging expenses. An otherwise desirable business
        venture may, however, decline to post such a deposit.

        The Company has no credit available to it and is unable to borrow
        money. Management does not anticipate raising funds through the sale
        of securities or otherwise, and it is unlikely that significant funds
        could be raised in a securities offering, in any event. This inabil-
        ity to raise funds could negatively affect the Company's realization
        of its business purpose.


Item 6. Exhibits and Reports on Form 8-K.

        (a)  Exhibits.  Exhibit 27 - Financial Data Schedule.

        (b)  Reports on Form 8-K.  NONE.


        
                              SIGNATURES
                              ----------

  In accordance with the requirements of the Exchange Act, the Registrant
caused this Report on Form 10-QSB to be signed on its behalf by the under-
signed, thereunto duly authorized.


DATED: October 20, 1997
                                   SIGMA-7 PRODUCTS, INC.





                                          /s/ Donald J. Smith
                                   By................................
                                          Chief Executive Officer
                                          and Chief Financial Officer




<TABLE> <S> <C>


        <S> <C>

<ARTICLE> 5
<LEGEND>

THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM
10-QSB FOR THE PERIOD ENDED JUNE 30, 1997 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FORM 10-QSB.

</LEGEND>
<MULTIPLIER> 1

<S>                           <C>
<PERIOD-TYPE>                 3-MOS
<FISCAL-YEAR-END>             SEP-30-1997
<PERIOD-END>                  JUN-30-1997
<CASH>                                 18
<SECURITIES>                            0
<RECEIVABLES>                           0
<ALLOWANCES>                            0
<INVENTORY>                             0
<CURRENT-ASSETS>                       18
<PP&E>                                  0
<DEPRECIATION>                          0
<TOTAL-ASSETS>                         18
<CURRENT-LIABILITIES>               3,337
<BONDS>                                 0
                   0
                             0
<COMMON>                          430,715
<OTHER-SE>                              0
<TOTAL-LIABILITY-AND-EQUITY>           18
<SALES>                                 0
<TOTAL-REVENUES>                        0
<CGS>                                   0
<TOTAL-COSTS>                           0
<OTHER-EXPENSES>                    1,591
<LOSS-PROVISION>                        0
<INTEREST-EXPENSE>                      0
<INCOME-PRETAX>                         0
<INCOME-TAX>                            0
<INCOME-CONTINUING>                (1,591)
<DISCONTINUED>                          0
<EXTRAORDINARY>                         0
<CHANGES>                               0
<NET-INCOME>                       (1,591)
<EPS-PRIMARY>                           0
<EPS-DILUTED>                           0


        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission